Hemorrhagic PED

Hemorrhagic PED results from blood leak via Bruch’s membrane to space between Bruch’s and RPE, causing an increase in hydrostatic pressure separating RPE from Bruch’s membrane.

Fundus image

On clinical exam, a smooth, well-defined border of RPE elevation and deep red color. PED is associated can be associated with subretinal fluid or intraretinal hemorrhage.

Fundus image showing hemorrhagic PED with subretinal hemorrhage

Optical coherence tomography

PED features smooth or irregular RPE elevation, which contains blood, and features hyperreflectivity beneath the RPE, followed by Hyporeflectivity below due to OCT signal block from the blood. PED may feature sub / intraretinal fluids and hemorrhage accompanied by ellipsoid zone disruption and, in some cases, intraretinal fluids.

OCT cross-section shows hemorrhagic PED with subretinal fluids

Fluorescein fundus angiography

On FFA, hemorrhagic PED shows hypofluorescence due to blood blocking the fluorescein dye along with subretinal fluid dye pooling, and sometimes associated choroidal neovascularization may exhibit leak.

Fundus image showing hemorrhagic PED with subretinal hemorrhage and exudation

Early FFA showing blocked fluorescence with hyperfluorescence from CNV

Early phase FFA showing bl ocked fluorescence from subretinal hemorrhage with hyperfluorescence from CNV

Mid phase FFA showing blocked fluorescence with hyperfluorescence from CNV and subretinal fluids

Mid phase FFA showing bloc ked fluorescence from subretinal hemorrhage with increased hyperfluorescence from CNV and subretinal fluids

Late phase FFA showing blocked fluorescence from subretinal hemorrhage with leakage from CNV and pooling from subretinal fluids

Management

Treating hemorrhagic PED is a clinical challenge with poor prognosis; however, better treatment response to VEGF trap (Aflibercept or Conbercept) in contrast to Anti VEGF (Bevacizumab or Ranibizumab),
If PED presented without any other retinal features such as active CNVm does not warrant treatment as regressing PED alone

won’t improve vision or prognosis.

Please check Clinical guidelines for ARMD and course of clinical changes in RPE

Comments

Cellophane maculopathy

Caused by an epiretinal membrane, clinically, it appears as a sheen abnormal foveal reflex which features epiretinal membrane, due to inflammatory mediators and proliferation of glial cells secondary to a partial separation of posterior cortical vitreous. Fundus image shows cellophane maculopathy OCT features a hyperreflective band covering the inner retinal layers, causing minimal disturbance of inner retinal tissues. OCT cross-section shows epiretinal membrane Cellophane maculopathy itself in individuals with good visual acuity may not need any interventions, but it is warranted to do a detailed peripheral retinal exam to rule out retinal tear or hole However, an epiretinal membrane may proliferate further and cause additional tangential traction. Thus, it may induce macular pucker or lamellar/pseudo hole and increase disturbance of inner retinal tissues, macular thickness, and reduction of vision. These patients may require pars plana vitrectomy to remove the epiretinal membran...

RPE tear, and it's OCT features in a nutshell

RPE tear can occur in vascularized PEDs due to a complication of intravitreal AntiVEGF treatment, which causes a rapid contraction of CNVm, inducing traction on the RPE surface and shrinking of RPE surface. On OCT, the RPE rip will indent the retina with increased hyperreflectivity in contracted RPE with underlying shadowing hinders choroidal view in contrast to the area where RPE where it ripped of which only Bruch's membrane is visible and increasing the visibility of the underlying choroid. RPE tear Thus two opposite forces, the regression of CNVm and remaining attached RPE, other causes such as laser or spontaneous can occur. However, the AntiVEGF treatment continued despite the RPE tear. Please check Clinical guidelines for ARMD and course of clinical changes in RPE

Diabetic macular edema with ischemic changes associated with very severe NPDR

A 51 years old male known to be diabetic for ten years with excellent glycemic control profile along with normal blood pressure presented with BCVA 20/100 in his left eye; he had a better vision of 20/30 in the same eye one year ago when he used to be on intravitreal injections of aflibercept, but he decided to discontinue intravitreal injection as been advised by another physician. Fundus image His fundus image shows cystic formation at the fovea with a sign of intraretinal dot and blots hemorrhages in the mid periphery with cotton wool spots and IRMA (Intra Retinal Microvascular Abnormalities). Fundus image showing macular edema with intraretinal hemorrhage and cotton wool spots Optical coherence tomography His OCT scan shows thickened central macular tissues with disorganization of inner retinal layers and non-empty cystic formation as it is classic findings of diabetic macular edema with some empty cystic formation; however, the ellipsoid zone looks intact. OCT cross-section for ce...

Retinal Assistant Module Blog

Search This Blog